Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,839 JPY | +0.05% | +0.60% | +3.31% |
2023 | ATyr Pharma to Obtain $10 Million in Milestone Payment After Partner Starts Dosing Patients in Lung Disease Study in Japan | MT |
2021 | KYORIN Holdings, Inc.(TSE:4569) dropped from S&P Japan 500 | CI |
Chart calendar KYORIN Pharmaceutical Co., Ltd.
Upcoming events on KYORIN Pharmaceutical Co., Ltd.
Past events on KYORIN Pharmaceutical Co., Ltd.
2024-03-27 | Final dividend |
2024-02-05 | Q3 2023 Earnings Release |
2023-11-07 | Q2 2023 Earnings Release |
2023-09-27 | Ex-dividend day for dividende intermédiaire |
2023-08-01 | Q1 2023 Earnings Call |
2023-08-01 | Q1 2023 Earnings Release |
2023-05-10 | Q4 2022 Earnings Release |
2023-03-29 | Ex-dividend day for final dividend |
2023-02-05 | Q3 2022 Earnings Release |
2022-11-08 | Interim 2022 Earnings Release |
2022-09-28 | Ex-dividend day for dividende intermédiaire |
2022-08-01 | Q1 2022 Earnings Release |
2022-05-10 | FY 2021 Earnings Release |
2022-03-29 | Ex-dividend day for final dividend |
2022-02-03 | Q3 2021 Earnings Call |
2022-02-03 | Q3 2021 Earnings Release |
2021-11-08 | Interim 2021 Earnings Call |
2021-11-07 | Interim 2021 Earnings Release |
2021-09-28 | Ex-dividend day for dividende intermédiaire |
2021-08-02 | Q1 2021 Earnings Release |
Past dividends on KYORIN Pharmaceutical Co., Ltd.
2024-03-27 | Final Payment 32 JPY |
2023-09-27 | Interim Payment 20 JPY |
2023-03-29 | Final Payment 32 JPY |
2022-09-28 | Interim Payment 20 JPY |
2022-03-29 | Final Payment 32 JPY |
2021-09-28 | Interim Payment 20 JPY |
2021-03-29 | Final Payment 45 JPY |
2020-09-28 | Interim Payment 30 JPY |
2020-03-29 | Final Payment 45 JPY |
2019-09-26 | Interim Payment 30 JPY |
Annual results
Fiscal Period | March | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million JPY | Released Forecast Spread | 113 620 112 600 0.91% | 109 983 113 100 -2.76% | 102 904 105 800 -2.74% | 105 534 108 300 -2.55% | 113 270 110 700 2.32% | 120 100 |
EBITDA Million JPY | Released Forecast Spread | 11 912 11 910 0.02% | 10 724 11 851 -9.51% | 9 350 10 415 -10.23% | 8 721 9 796 -10.97% | 8 963 9 820 -8.73% | 10 984 |
EBIT Million JPY | Released Forecast Spread | 8 972 8 900 0.81% | 7 503 8 100 -7.37% | 5 786 6 400 -9.59% | 5 007 5 600 -10.59% | 5 123 5 700 -10.12% | 6 400 |
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | 9 359 9 348 0.12% | 8 255 8 799 -6.18% | 8 352 6 970 19.83% | 5 216 6 243 -16.45% | 6 906 6 160 12.11% | 7 126 |
Net income Million JPY | Released Forecast Spread | 6 869 6 700 2.52% | 6 149 6 600 -6.83% | 6 130 5 190 18.11% | 3 932 4 430 -11.24% | 4 723 4 620 2.23% | 5 380 |
EPS JPY | Released Forecast Spread | 105 117 -10.61% | 107 115 -6.82% | 107 90,6 18.09% | 68,6 77,3 -11.24% | 82,4 80,6 2.28% | 93,6 |
Announcement Date | 13/05/19 | 12/05/20 | 11/05/21 | 11/05/22 | 11/05/23 | - |
Quarterly results
Fiscal Period | March | 2020 S1 | 2021 S1 | 2022 S1 | 2022 Q3 | 2023 Q1 | 2023 S1 | 2023 Q3 | 2024 Q1 | 2024 S1 | 2024 Q3 |
---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million JPY | Released Forecast Spread | 48 299 | 47 735 | 49 102 | 28 615 | 24 619 | 49 093 | 31 614 | 27 854 | 54 937 | 32 330 |
EBIT Million JPY | Released Forecast Spread | 783 | 1 502 | -68,0 | 2 994 | 489 | 777 | 3 925 | 710 | 1 144 | 3 321 |
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | 1 178 | 2 874 | 269 | 3 229 | 1 658 | 1 812 | 4 149 | 913 | 2 349 | 2 801 |
Net income Million JPY | Released Forecast Spread | 834 | 2 118 | 121 | 2 362 | 1 183 | 1 242 | 3 135 | 676 | 1 757 | 2 157 |
EPS JPY | Released Forecast Spread | 14,6 | 37,0 | 2,12 | 41,2 | 20,7 | 21,7 | 54,7 | 11,8 | 30,7 | 37,6 |
Announcement Date | 07/11/19 | 05/11/20 | 08/11/21 | 04/02/22 | 02/08/22 | 09/11/22 | 06/02/23 | 02/08/23 | 08/11/23 | 06/02/24 |
Past sector events for KYORIN Pharmaceutical Co., Ltd.
2024-05-03 07:07 am | AARTI DRUGS LIMITED: Q4 2024 Earnings Release |
2024-05-03 06:00 am | AMNEAL PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
2024-05-02 | SCINOPHARM TAIWAN, LTD.: Q1 2024 Earnings Release (Projected) |
2024-05-02 | DEVA HOLDING: Q1 2024 Earnings Release (Projected) |
2024-05-02 04:01 pm | AMGEN INC.: Q1 2024 Earnings Release |
2024-05-02 01:43 pm | ALK-ABELLÓ A/S: Q1 2024 Earnings Release |
2024-05-02 07:30 am | ORGANON & CO.: Q1 2024 Earnings Release |
2024-05-02 07:00 am | BAUSCH HEALTH COMPANIES INC.: Q1 2024 Earnings Release |
2024-05-02 01:30 am | NOVO NORDISK A/S: Q1 2024 Earnings Release |
2024-05-01 | GC BIOPHARMA CORP.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 4569 Stock
- Calendar KYORIN Pharmaceutical Co., Ltd.